iShares突破性环境解决方案ETF ETEC 深 沪
等待开盘 02-05 09:30:00 美东时间
27.49
+0.554
+2.06%
华盛通- 最 高27.72
- 今 开27.72
- 成交量 416股
- 最 低 27.49
- 昨 收 26.9358
- 总市值 439.84万
- 52周最高 27.72
- 市盈率 静 --
- 换手率 0.26%
- 52周最低 15.6343
- 委 比 -33.33%
- 总股本 16.00万
- 历史最高 27.72
- 量 比 0.29
- 振 幅 0.85%
- 历史最低 15.6343
- 每 手 1
- 风险率 2.83%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Allegro MicroSystems Board Deems ON Semiconductor's $6.9B Offer 'Inadequate'
Allegro MicroSystems receives offer from ON Semiconductor for $35.10/share, with an implied EV of $6.9B. Allegro deemed onsemi's proposal inadequate.
2025-03-06 18:53
BRIEF-Idexx Announces Groundbreaking Cancer Dx Panel
Jan 23 (Reuters) - IDEXX Laboratories Inc IDXX.O: IDEXX ANNOUNCES GROUNDBREAKING CANCER DX PANEL WITH AFFORDABLE EARLY DETECTION TEST FOR CANINE LYMPHOMA Source text: ID:nPn2fCWsMa Further company cov...
2025-01-23 20:15
BRIEF-Neogen® Launches New MDA2 Quantitative Salmonella Molecular Detection Assay
Jan 16 (Reuters) - Neogen Corp NEOG.O: NEOGEN® LAUNCHES NEW MDA2 QUANTITATIVE SALMONELLA MOLECULAR DETECTION ASSAY Source text: ID:nPn9FG13Za Further company coverage: NEOG.O ((Reuters.Briefs@thomsonr...
2025-01-16 21:51
BRIEF-United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer
Jan 16 (Reuters) - Biomerica Inc BMRA.O: BIOMERICA: UNITED ARAB EMIRATES MINISTRY OF HEALTH AND PREVENTION APPROVES FORTEL PSA SCREENING TEST TO DETECT EARLY SIGN OF PROSTATE CANCER Source text: ID:nG...
2025-01-16 21:35
BRIEF-Quanterix To Acquire Akoya Biosciences
Jan 10 (Reuters) - Akoya Biosciences Inc AKYA.O: QUANTERIX TO ACQUIRE AKOYA BIOSCIENCES, CREATING THE FIRST INTEGRATED SOLUTION FOR ULTRA-SENSITIVE DETECTION OF BLOOD- AND TISSUE-BASED PROTEIN BIOMARK...
2025-01-10 20:29
BRIEF-Guardant Health Shield Platform Selected For Inclusion In National Cancer Institute’S Vanguard Study To Evaluate Emerging Technologies For Multi-Cancer Detection
Jan 7 (Reuters) - Guardant Health Inc GH.O: GUARDANT HEALTH SHIELD PLATFORM SELECTED FOR INCLUSION IN NATIONAL CANCER INSTITUTE’S VANGUARD STUDY TO EVALUATE EMERGING TECHNOLOGIES FOR MULTI-CANCER DETE...
2025-01-07 21:18
